Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-24-001779
Filing Date
2024-11-07
Accepted
2024-11-07 07:11:46
Documents
67
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q zura-20240930x10q.htm   iXBRL 10-Q 1867266
2 EX-31.1 zura-20240930xex31d1.htm EX-31.1 14561
3 EX-31.2 zura-20240930xex31d2.htm EX-31.2 15197
4 EX-32.1 zura-20240930xex32d1.htm EX-32.1 8618
5 EX-32.2 zura-20240930xex32d2.htm EX-32.2 8656
  Complete submission text file 0001410578-24-001779.txt   7497944

Data Files

Seq Description Document Type Size
6 EX-101.SCH zura-20240930.xsd EX-101.SCH 65661
7 EX-101.CAL zura-20240930_cal.xml EX-101.CAL 36094
8 EX-101.DEF zura-20240930_def.xml EX-101.DEF 309541
9 EX-101.LAB zura-20240930_lab.xml EX-101.LAB 536740
10 EX-101.PRE zura-20240930_pre.xml EX-101.PRE 445990
70 EXTRACTED XBRL INSTANCE DOCUMENT zura-20240930x10q_htm.xml XML 967527
Mailing Address 4225 EXECUTIVE SQUARE SUITE 600 LA JOLLA CA 92037
Business Address 4225 EXECUTIVE SQUARE SUITE 600 LA JOLLA CA 92037 858-247-0520
Zura Bio Ltd (Filer) CIK: 0001855644 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40598 | Film No.: 241433132
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)